Inducible nitric oxide synthase and nitric oxide production in Leishmania infantum-infected human macrophages stimulated with interferon-γ and bacterial lipopolysaccharide

International Journal of Clinical and Laboratory Research

Volumn 29, Issue 3, 1999, Pages 122-127

  Panaro, M A ^a   Acquafredda, A ^a   Lisi, S ^a   Lofrumento, D D ^a   Trotta, T ^a   Satalino, R ^a   Saccia, M ^a   Mitolo, V ^a   Brandonisio, O ^b  

^a UNIVERSITY OF BARI   (Italy)

^b POLICLINICO   (Italy)

Author keywords

Inducible nitric oxide synthase; Leishmania; Leishmaniasis; Nitric oxide

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOS2A PROTEIN, HUMAN; RECOMBINANT GAMMA INTERFERON;

ANIMAL; ARTICLE; BIOSYNTHESIS; DRUG EFFECT; HUMAN; IMMUNOLOGY; IN VITRO STUDY; LEISHMANIA INFANTUM; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; PARASITOLOGY; PATHOGENICITY;

ANIMALS; HUMANS; INTERFERON-GAMMA, RECOMBINANT; LEISHMANIA INFANTUM; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 0032762414     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005990050076     Document Type: Article

References (45)

1. MacMicking J, Xie Q-w, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15:323.
2. Mauël J. Intracellular survival of protozoan parasites with special reference to Leishmania spp., Toxoplasma gondit and Trypanosoma cruzi. Adv Parasitol 1996; 38:1.
3. Diefenbach A, Schindler H, Röllinghoff M, Yokoyama WM, Bodgan C. Requirement for type 2 NO synthase for IL-12 signalling in innate immunity. Science 1999; 284:951.
4. Gradoni L, Scalone A, Gramiccia M, Troiani M. Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy. AIDS 1996; 10:785.
5. Brandonisio O, Carelli G, Ceci L, Consenti B, Fasanella A, Puccini V. Canine leishmaniasis in the Gargano Promontory (Apulia, South Italy). Eur J Epidemiol 1992; 8:273.
6. Green SJ, Meltzer MS, Hibbs JB, Nacy CA. Activated macrophages destroy Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol 1990; 144:278.
7. Mauel J, Ransijn A, Buchmüller-Rouiller Y. Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivates. J Leukoc Biol 1991; 49:73.
8. Liew FY, Yun L, Millot S. TNF-α synergizes with IFN-γ in mediating killing of Leishmania major throught the induction of nitric oxide. J Immunol 1990; 145:4306.
9. Stenger S, Donhauser N, Thuring H, Rollinghoff M, Bodgan C. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 1996; 183:1501.
10. Wei XQ, Charles IG, Smith A, Ure J, Feng CJ, Huang FP, Xu DM, Muller W, Moncada S, Liew FY. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995; 375:408.
11. Liew FY, Wei X-Q, Proudfoot L. Cytokines and nitric oxide as effector molecules against parasitic infections. Philas Trans R Soc Lond B Biol Sci 1997; 352:1311.
12. Piedrafita D, Proudfoot L, Nikolaev AV, Xu DM, Sands W, Feng GJ, Thomas E, Brewer J, Ferguson MAJ, Alexander J, Liew FY. Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans. Eur J Immunol 1999; 29:235.
13. Bogdan C, Röllinghoff M. How do protozoan parasites survive inside macrophages? Parasitol Today 1999; 15:22.
14. Schneemann M, Shoedon G, Linscheid P, Walter R, Blau N, Shaffner A. Nitrite generation in interleukin-4-treated human macrophages cultures does not involve the nitric oxide pathway. J Infect Dis 1997; 175:130.
15. Zhang X, Laubach VE, Alley EW, Edwards KA, Sherman PA, Russel SW, Murphy WJ. Transcriptional basis for hyporesponsiveness of the human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-γ. J Leukoc Biol 1996; 59:575.
16. Kroncke KD, Fehsel K, Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 1998; 113:147.
17. Panaro MA, Fasanella A, Lisi S, Mitolo V, Andriola A, Brandonisio O. Evaluation of nitric oxide production by Leishmania infantum-infected dog macrophages. Immunopharmacol Immunotoxicol 1998; 20:147.
18. Panaro MA, Lisi S, Mitolo V, Acquafredda A, Fasanella A, Carelli MG, Brandonisio O. Evaluation of killing, superoxide anion and nitric oxide production by Leishmania infantum-infected dog monocytes. Cytobios 1998; 95:151.
19. Evans DA. In: Taylor AER, Baker JR, eds. Methods of cultivating parasites in vitro. London: Academic Press; 1978: 55-58.
20. Ding AH, Nathan CF, Stuher DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J Immunol 1988; 141:2407.
21. Pantazis CG, Kniker WT. Assessment of blood leukocyte microbial killing by using a new fluoro-chrome microassay. J Reticuloendothel Soc 1979; 26:155.
22. Xie Q-w, Cho H, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages Science 1992; 256:225.
23. Weinberg JB, Misukonis MA, Shami PJ, Mason SN, Sauls DL, Dittman WA, Wood ER, Smith GK, McDonald B, Bachus KE, Haney AF, Granger DL. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA. iNOs protein, biopterin, and nitric oxide production by blood monocytes and peripheral macrophages. Blood 1995; 86:1184.
24. Zembala M, Siedlar M, Marcinkiewicz J, Pryjma J. Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipolysaccharide. Eur J Immunol 1994; 24:435.
25. Kolyada AY, Savikovsky N, Madias NF. Transcriptional regulation of the human iNOS gene in vascular-smooth-muscle cells and macrophages: evidence for tissue-specificity. Biochem Biophys Res Commun 1996; 220:600.
26. Villalta F, Zhang Y, Bibb KE, Kappes JC, Lima MF. The cysteine-cysteine family of chemokines RANTES. MIP-1α, and MIP-1β induce trypanocidal activity in human macrophages via nitric oxide. Infect Immun 1998; 66:4690.
27. Dumarey CH, Labrousse V, Rastogi N, Vargagtig BB, Bachelet M. Selective Mycobacterium avium-induced production of nitric oxide by human monocyte-derived macrophages. J Leukoc Biol 1994; 56:36.
28. Bukrinsky MI, Nottet HSLM, Schmidtmayerova N, Dubrovsky L, Mullins ME, Lipton SA, Gendelman HE. Regulation of nitric oxide synthase activity in HIV-1-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1995; 181:735.
29. Snell JC, Chernyshev O, Gilbert DL, Colton CA. Polyribonucleotides induce nitric oxide production by human monocyte-derived macrophages. J Leukoc Biol 1997; 62:369.
30. Bonecini-Almeida MG, Chitale S, Boutsikakis I, Geng JY, Doo H, He SH, Ho JL. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-γ and primed lymphocytes. J Immunol 1998; 160: 4490.
31. Vouldoukis I, Riveros-Moreno V, Dugas B, Ouaaz F, Bécherel P, Debré P, Moncada S, Mossalayi MD. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FcεRII/CD23 surface antigen. Proc Natl Acad Sci U S A 1995; 92:7804.
32. Vouldoukis I, Bécherel P, Riveros-Moreno V, Arock M, Silva O da, Debré P, Mazier D, Mossalayi MD. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol 1997; 27:860.
33. Gross A, Dugas N, Spiesser S, Vouldoukis I, Damais C, Kolb JP, Dugas B, Dornand J. Nitric oxide production in human macrophagic cells phagocytizing opsonized zymosan: direct characterization by measurement of the luminol-dependent chemiluminescence. Free Radie Res 1998; 28:179.
34. Moilanen E, Moilanen T, Knowles R, Charles I, Kadoya Y, Al-Saffar N, Revell PA, Moncada S. Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am J Pathol 1997; 150:881.
35. Watkins SC, Macaulay W, Turner D, Kang R, Rubash HE, Evans CH. Identification of inducible nitric oxide synthase in human macrophages surrounding loosened hip prostheses. Am J Pathol 1997; 150:1199.
36. López-Jaramillo P, Ruano C, Rivera J, Terán E, Salazar-Irigoyen R, Esplugues JV, Moncada S. Treatment of cutaneous leishmaniasis with nitric oxide donor (letter). Lancet 1998; 351:1176.
37. Rockett KA, Brookes R, Udalova I, Vidai V, Hill AVS, Kwiatkowski D. 1,25-Dihydroxyvitamin D-3 induces nitricoxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 1998; 66:5314.
38. Buates S, Matlashewski G. Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action. J Infect Dis 1999; 179: 1485.
39. Tarrant TK, Silver PB, Wahlsten JL, Rizzo LV, Chan CC, Wiggert B, Caspi RR. Interleukin-12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon-γ, nitric oxide, and apoptosis. J Exp Med 1999; 189:219.
40. MacFarlane AS, Huang D, Schwacha MG, Meissler JJ, Gauhan JP, Eisenstein TK. Nitric oxide-mediated immunosuppression induced by Listeria monocytogenes infection: quantitative studies. Microb Pathog 1998; 25:267.
41. MacFarlane AS, Schwacha MG, Eisenstein TK. In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen. Infect Immun 1999; 67:891.
42. Piedrafita D, Liew FY. Nitric oxide: a protective or pathogenic molecule? Rev Med Microbiol 1998; 9:179.
43. Huang FP, Niedbala W, Wei XQ, Xu DM, Feng GJ, Robinson JH, Lam C: Liew FY. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur J Immunol 1998; 28:4062.
44. Giorgio S, Linares E, Ischiropoulos H, VonZuben FJ, Yamada A, Augusto O. In vivo formation of electron paramagnetic resonance-detectable nitric oxide and of nitrotyrosine is not impaired during murine leishmaniasis. Infect Immun 1998; 66:807.
45. Nappi AJ, Vass E. Hydroxyl radical formation resulting from the interaction of nitric oxide and hydrogen peroxide. Biochim Biophys Acta 1998; 1380:55.